Structure |
Chemical Name |
CAS |
MF |
|
Lixivaptan intermediate-IV |
179063-21-9 |
C19H14ClN3O3 |
|
Posaconazole Diastereoisomer 12 |
213381-04-5 |
C37H42F2N8O4 |
|
tert-butyl(R)-3-((6-chloropyrazin-2-yl)oxy)piperidine-1-carboxylate |
1147998-31-9 |
C14H20ClN3O3 |
|
3-Aminopyrazole |
1820-80-0 |
C3H5N3 |
|
1-[4-Bromo-3-(bromomethyl)phenyl]ethanone |
1844064-91-0 |
C9H8Br2O |
|
tert-butyl 3-oxohexahydroimidazo[1,5-a]pyrazine-7(1H)-carboxylate |
1246551-25-6 |
C11H19N3O3 |
|
Velpatasvir intermediate |
1378391-43-5 |
C44H55N3O13 |
|
Safinamide-d4 |
1147299-69-1 |
C17H19FN2O2 |
|
tert-butyl 4-(chloromethyl)-4-(hydroxymethyl)piperidine-1-carboxylate |
1312131-45-5 |
C12H22ClNO3 |
|
tert-butyl(4S)-4-methyl-2,2-dioxo-1,2λ,3-oxathiazolidine-3-carboxylate |
439948-91-1 |
C8H15NO5S |
|
Tosylate of Triethylene glycol monobenzyl ether |
84131-04-4 |
C20H26O6S |
|
2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline |
1609394-10-6 |
C10H12N4O |
|
CarbaMic acid, [(1S)-3-Methyl-1-(2-Methylpropyl)-2-oxo-3-butenyl]-, 1,1-diMethylethyl ester (9CI) |
247068-81-1 |
C14H25NO3 |
|
interMediates of eletriptan hydrobroMide |
180637-88-1 |
C24H26N2O3S |
|
6-(4-Chlorophenyl)-2,3-Dihydro-2,2-DiMethyl-7-Phenyl-1H-Pyrrolizine |
133111-56-5 |
C21H20ClN |
|
4,8-dichloropyrido[3,4-d]pyriMidine |
1260663-37-3 |
C7H3Cl2N3 |
|
2-Propenoic acid, 3-[(4'-cyano[1,1'-biphenyl]-4-yl)oxy]propyl ester |
104357-57-5 |
C19H17NO3 |
|
6-BroMo-3-AMino-4-quinolinol |
1153094-27-9 |
C9H7BrN2O |
|
5-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE |
866319-00-8 |
C7H5FN2 |
|
N(4)-methylcytidine |
10578-79-7 |
C10H15N3O5 |
|
qianhucoumarin A |
150135-35-6 |
C19H20O6 |
|
Dimethyl cyclopentane-1,3-dicarboxylate |
2435-36-1 |
C9H14O4 |
|
Ethyl N-Cbz-4-Oxopyrrolidine-3-carboxylate |
51814-19-8 |
C15H17NO5 |
|
lupinine hydrochloride |
6113-09-3 |
C10H20ClNO |
|
METHYL ESTER, 4,5-BIS(2-METHOXYETHOXY)-2-NITROBENZOIC ACID |
501684-22-6 |
C14H19NO8 |
|
2-BROMO-7-METHYL-5H-[1,3,4]THIADIAZOLO[3,2-A]PYRIMIDIN-5-ONE |
139535-51-6 |
C6H4BrN3OS |
|
TERT-BUTYL4-(3-PHENYLPROPYL)-1,4-DIAZEPANE-1-CARBOXYLATE |
198895-74-8 |
C19H30N2O2 |
|
(aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate |
179324-87-9 |
C17H29BF3NO4 |
|
1,2,4-thiadiazole |
288-92-6 |
C2H2N2S |
|
TERT-BUTYL 3-BROMO-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE-7(8H)-CARBOXYLATE |
723286-80-4 |
C10H15BrN4O2 |
|
1-Boc-2,5-Dihydro-1H-pyrrole-3-boronic acid, pinacol ester |
212127-83-8 |
C15H26BNO4 |
|
4,5-DICHLORO-QUINOLINE |
21617-18-5 |
C9H5Cl2N |
|
2-Amino-5-bromo-3-(hydroxymethyl)pyridine |
335031-01-1 |
C6H7BrN2O |
|
exo-3-Boc-3-azabicyclo[3.1.0]hexane-6-methanol |
419572-18-2 |
C11H19NO3 |
|
(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol |
153004-31-0 |
C32H47F5O2S |
|
(1R,4S,4aR,9aS)-rel-1,4,4a,9a-Tetrahydro-4a-methyl-1,4-methanoanthracene-9,10-dione |
97804-50-7 |
C16H14O2 |
|
Methyl (3R)-3-Morpholinecarboxylate |
1187933-47-6 |
C6H11NO3 |
|
6-Chloro-1H-pyrazolo[4,3-c]pyridine |
1206979-33-0 |
C6H4ClN3 |
|
3-Azetidinol, 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-, (2Z)-2-butenedioate (1:1) |
519187-97-4 |
C20H25NO6S |
|
6-broMo-4-hydroxyquinolin-2(1H)-one |
54675-23-9 |
C9H6BrNO2 |
|
1-Bromo-9H-carbazole |
16807-11-7 |
C12H8BrN |
|
4-broMo-2-(1,1,1-trifluoro-2-Methylpropan-2-yl)pyridine |
1357476-67-5 |
C9H9BrF3N |
|
TFA-ap-dC |
115899-38-2 |
C14H15F3N4O5 |
|
(alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride |
521284-22-0 |
C16H21ClN2O |
|
(R)-tert-butyl 4-(4-(6-aMino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate |
877399-51-4 |
C26H30Cl2FN5O3 |
|
3-Iodo-1H-pyrazole-4-carbonitrile |
827316-44-9 |
C4H2IN3 |
|
Posaconazole EnantioMer |
|
|
|
2-Methylpyrazolo[1,5-a]pyriMidin-5-ol |
189116-35-6 |
C7H7N3O |
|
(αR,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1,2,4-triazole-1-butanoic Acid |
483340-19-8 |
C13H13F2N3O3 |
|
2-BroMo-1-(pyriMidin-2-yl)ethanone hydrobroMide |
1588441-02-4 |
C6H6Br2N2O |
|
6-[[[4-[(1-Oxo-2-propen-1-yl)oxy]butoxy]carbonyl]oxy]-2-naphthalenecarboxylic acid 2,2'-[2-(methoxycarbonyl)-1,4-phenylene] ester |
914918-26-6 |
C46H40O16 |
|
Methyl 1-(MethylaMino)cyclobutanecarboxylate hydrochloride |
1247180-93-3 |
C7H13NO2 |
|
Ethyl 2-aMinopyriMidine-4-carboxylate |
916056-77-4 |
C7H9N3O2 |
|
3-Bromo-4'-chloro-1,1'-biphenyl |
164334-69-4 |
C12H8BrCl |
|
4,4',4'',4'''-(pyrene-1,3,6,8-tetrayl)tetrabenzaldehyde |
1415238-25-3 |
C44H26O4 |
|
2-phenylpyrimidine-4-carbaldehyde |
1014-07-9 |
C11H8N2O |
|
1,2,3-TRI[CIS-6-OCTADECENOYL]GLYCEROL |
3296-43-3 |
C57H104O6 |
|
(4-Fluoro-phenyl)-piperidin-4-yl-amine dihydrochloride |
1193389-70-6 |
C11H17Cl2FN2 |
|
Methylamine hydrochloride Solid Methylamine hcl vendor [email protected] |
|
CH6ClN |
|
6-Chloro-2,3,4,5-tetrahydro-7,8-dimethoxy-1-(4-methoxyphenyl)-1H-3-benzazepine |
67287-53-0 |
C19H22ClNO3 |
|
Phosphonic acid, (3-methyloxiranyl)-, (2R-cis)-, compd. with (R)-alpha-methylbenzenemethanamine (1:1), monohydrate (9CI) |
65794-75-4 |
C11H18NO4P |
|
benzyl 3-ethyl-4-methyl-1H-pyrrole-2-carboxylate |
5866-56-8 |
C15H17NO2 |
|
4-methyl-8-nitro-2H- chromen-2-one |
184290-97-9 |
C10H7NO4 |
|
(5-chloro-2-ethoxycarbonyl-7-morpholin-4-yl)pyrazolo[1,5-a]pyrimidine |
1232224-64-4 |
C13H15ClN4O3 |
|
Oseltamivir Fructose Adduct 1 |
|
|
|
(S)-oxetan-2-ylmethanamine |
2091328-57-1 |
C4H9NO |
|
Cephalexin ethyl homologue |
|
|
|
4-Morpholinecarboxylic acid, 2-ethynyl-, 1,1-dimethylethyl ester, (2S)- |
1621165-19-2 |
C11H17NO3 |
|
(S)-2-((trifluoromethoxy)methyl)piperazine |
|
|
|
(S)-2-(2-fluoroethyl)piperazine dihydrochloride |
|
|
|
tert-butyl (R)-2-(2,2,2-trifluoroethyl)piperazine-1-carboxylate |
1240586-07-5 |
C11H19F3N2O2 |
|
(2S,5S)-tert-butyl 5-hydroxypiperidine-2-carboxylate(2S,5S)-tert-butyl 5-hydroxypiperidine-2-carboxylate |
1383814-52-5 |
C10H19NO3 |
|
Ethyl 3-hydroxy-4-oxo-4,6,7,9-tetrahydropyrimido[2,1-c][1,4]oxazine-2-carboxylate |
870562-00-8 |
C10H12N2O5 |
|
4'-(4-BROMOPHENYL)-2,2':6',2''-TERPYRIDINE |
89972-76-9 |
C21H14BrN3 |
|
Canagliflozin Intermediate epimers |
|
|
|
(3R,4S,5S)-Oseltamivir |
|
|
|
1(2H)-Pyridinecarboxylic acid, 2-(aminocarbonyl)-5-[[(1,1-dimethylethoxy)carbonyl]hydroxyamino]-5,6-dihydro-3-methyl-, 1,1-dimethylethyl ester, (2S,5R)- |
2209872-72-8 |
C17H29N3O6 |
|
INDEX NAME NOT YET ASSIGNED |
2070009-39-9 |
C35H39N5O10 |
|
(9H-fluoren-9-yl)methyl ((2S,3R)-3-hydroxy-1-(methylamino)-1-oxobutan-2-yl)carbamate |
|
|
|
1-METHYL-1,2,3,4-TETRAHYDRO-QUINOXALINE DIHYDROCHLORIDE |
36438-97-8 |
C9H12N2 |
|
Etodesnitazene |
14030-76-3 |
C22H29N3O |
|
1,4-BIS-[4-(6-ACRYLOYLOXYHEXYLOXY)BENZOYLOXY]-2-METHYLBENZENE |
125248-71-7 |
C39H44O10 |
|
(S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one |
156732-13-7 |
C32H32N2O |
|
4-butyl-1,2-diphenylpyrazolidine-3,5-dione, compound with piperazine (1:1) |
4985-25-5 |
C23H30N4O2 |
|
pinanyl hydroperoxide |
28324-52-9 |
C10H18O2 |
|
iodomethyl (2S-cis)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide |
76247-39-7 |
C9H12INO5S |
|
Intermediate 1 |
2203433-07-0 |
C17H16N2O5 |
|
8-bromoxanthosine |
3001-46-5 |
C10H11BrN4O6 |
|
8-arm Poly(ethylene glycol) succinimidyl carbonate(HG) |
|
|
|
tert-butyl 3-(2-((2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carbonyl)hydrazine-1-carbonyl)pyrrolidine-1-carboxylate |
1452467-45-6 |
C24H33N5O6 |
|
Phenol, 5-(ethylamino)-2-[2-(2-hydroxyphenyl)diazenyl]-4-methyl- (ACI) |
1225219-08-8 |
C15H17N3O2 |
|
N-Boc-4-piperidinemethanol |
123855-51-6 |
C11H21NO3 |
|
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |
1062580-52-2 |
C14H23ClN2 |
|
(+)-(1R,5S)-2-Oxabicyclo[3.3.0]oct-6-en-3-one |
26054-46-6 |
C7H8O2 |
|
4-isothiocyanato-2-(trifluoroMethyl)benzonitrile |
143782-23-4 |
C9H3F3N2S |
|
Amic acid |
|
|
|
(3R)-3-dodecanoyloxy-4-trimethylammonio-butanoate |
25518-54-1 |
C19H37NO4 |
|
ATORVASTATIN SODIUM |
134523-01-6 |
C33H36FN2NaO5 |
|
1,2,5-oxadiazole |
288-37-9 |
C2H2N2O |
|
4-Oxazolidinecarboxylicacid,2-oxo-,methylester,(4R)-(9CI) |
144542-43-8 |
C5H7NO4 |